Antithrombotic Management of Acute Mesenteric Ischaemia

Universitaire Ziekenhuizen KU Leuven

Status: Completed

Conditions: Short Bowel Syndrome; Acute Mesenteric Ischemia

Treatments: Other: Survey

Study type: Observational

Funder types: Other

Identifiers

NCT05706012

s67503

Details and patient eligibility

About

Guidelines on the acute and long-term pharmacological treatment of acute mesenteric ischaemia (AMI) recommend the use of thrombolytic, antiplatelet or anticoagulant therapy depending on the aetiology of AMI and the use of stenting but only few details are given on the choice of the drug, dose and duration of treatment. Besides, recommendations are mainly based on data on coronary, cerebral and other peripheral artery diseases and do also not take into account the altered drug absorption in patients with short bowel syndrome, in which AMI can result.This case-based survey will inform us on the current international clinical practice of long-term antithrombotic management of AMI.

Enrollment: 51 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• gastro-enterologist or cardiologist with expertise in treating SBS patients resulting from AMI

Exclusion criteria

• none

Trial design

51 participants in 1 patient group

Gastro-enterologists and anticoagulation specialists

Description:

An online survey will be sent to question current clinical practice in long-term antithrombotic management of AMI in SBS patients.

Treatment:

Other: Survey